|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$122,669,124 |
|
|
Indirect Value
|
$38,294,297 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$160,963,421 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 17 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KPRX |
Kiora Pharmaceuticals |
Director |
|
2018-12-11 |
4 |
B |
$0.41 |
$12,842 |
D/D |
30,953 |
17,262,853 |
3.92 |
- |
|
KPRX |
Kiora Pharmaceuticals |
10% Owner |
|
2018-05-10 |
4 |
B |
$0.54 |
$12,982 |
D/D |
23,917 |
16,677,600 |
2.37 |
- |
|
ONTX |
Onconova Therapeutics, In... |
10% Owner |
|
2019-09-23 |
4 |
S |
$1.27 |
$13,016 |
D/D |
(10,249) |
816,702 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-15 |
4 |
S |
$0.16 |
$13,133 |
D/D |
(82,084) |
16,141,492 |
0 |
% |
|
FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
|
2018-06-25 |
4 |
B |
$1.26 |
$13,462 |
D/D |
10,672 |
3,042,776 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-08-24 |
4 |
B |
$0.70 |
$13,943 |
D/D |
19,944 |
15,755,709 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-11-30 |
4 |
B |
$3.50 |
$14,351 |
D/D |
4,102 |
17,981,905 |
3.92 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-21 |
4 |
S |
$0.15 |
$15,000 |
D/D |
(100,000) |
15,916,492 |
0 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-08-17 |
4 |
B |
$0.59 |
$15,245 |
D/D |
26,002 |
15,668,302 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-05-19 |
4 |
B |
$0.63 |
$15,261 |
D/D |
24,224 |
3,384,224 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-11 |
4 |
B |
$0.96 |
$15,342 |
I/I |
16,003 |
45,645,000 |
2.17 |
% |
|
KPRX |
Kiora Pharmaceuticals |
Director |
|
2019-09-30 |
4 |
B |
$3.11 |
$15,613 |
D/D |
5,001 |
1,792,500 |
3.92 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-12-24 |
4 |
B |
$0.32 |
$16,260 |
D/D |
50,000 |
19,850,000 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-07-02 |
4 |
B |
$4.28 |
$16,276 |
D/D |
3,800 |
16,418,200 |
3.92 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-12-20 |
4 |
B |
$0.33 |
$16,520 |
D/D |
50,000 |
19,800,000 |
2.37 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2019-03-25 |
4 |
B |
$0.33 |
$16,530 |
D/D |
50,000 |
19,900,000 |
2.37 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
|
2018-06-18 |
4 |
B |
$1.20 |
$16,532 |
D/D |
13,742 |
3,013,742 |
2.37 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-12-07 |
4 |
B |
$0.33 |
$16,650 |
D/D |
50,000 |
19,600,000 |
2.37 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-12-10 |
4 |
B |
$0.33 |
$16,746 |
D/D |
50,000 |
19,650,000 |
2.37 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-12-19 |
4 |
B |
$0.34 |
$16,795 |
D/D |
50,000 |
19,750,000 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-05-28 |
4 |
B |
$4.92 |
$17,220 |
D/D |
3,500 |
18,363,285 |
3.92 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-12-18 |
4 |
B |
$0.35 |
$17,285 |
D/D |
50,000 |
19,700,000 |
2.37 |
- |
|
KPRX |
Kiora Pharmaceuticals |
10% Owner |
|
2018-05-08 |
4 |
B |
$0.48 |
$17,718 |
D/D |
37,230 |
16,549,730 |
2.37 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-12-06 |
4 |
B |
$0.36 |
$17,845 |
D/D |
50,000 |
19,550,000 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-05-04 |
4 |
B |
$0.63 |
$17,900 |
D/D |
28,413 |
3,144,201 |
2.37 |
- |
|
790 Records found
|
|
Page 17 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|